Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT06156059
What this trial is testing

Oral Bedtime Melatonin in Critically Ill Patients

Who this might be right for
Septic ShockStroke HemorrhagicStrokes Thrombotic+1 more
Hospital San Carlos, Madrid 160
Not applicableNot Yet RecruitingNCT07798050
What this trial is testing

Selective Mediterranean Diet in Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaIdiopathic Thrombocytopenic PurpuraThrombocytopenia
Assiut University 60
Not applicableLooking for participantsNCT07612319
What this trial is testing

Romiplostim for Oral TPO-RA Resistant ITP

Who this might be right for
Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
The First Affiliated Hospital of Soochow University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07234019
What this trial is testing

Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)UnknownNCT05124028
What this trial is testing

Orelabrutinib in Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT07063199
What this trial is testing

Anti-CD38 Antibody Treating Elderly Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 30
Not applicableStudy completedNCT03481257
What this trial is testing

Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel

Who this might be right for
Acute Coronary SyndromeAcute Myocardial InfarctionUnstable Angina
Seoul National University Hospital 56
Not applicableStudy completedNCT04749810
What this trial is testing

Observational Study of Elizaria® in aHUS Patients

Who this might be right for
Atypical Hemolytic Uremic SyndromeaHUS
AO GENERIUM 50
Large-scale testing (Phase 3)Study completedNCT02878603
What this trial is testing

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

Who this might be right for
Acquired Thrombotic Thrombocytopenic Purpura
Sanofi 104
Not applicableUnknownNCT05333861
What this trial is testing

An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA

Who this might be right for
Primary Immune ThrombocytopeniaAplastic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,150
Testing effectiveness (Phase 2)UnknownNCT06176911
What this trial is testing

The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 124
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Not applicableUnknownNCT05068375
What this trial is testing

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

Who this might be right for
COVID-19
Sohag University 150
Not applicableLooking for participantsNCT06947707
What this trial is testing

Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients

Who this might be right for
Cerebral Venous ThrombosisAnticoagulants and Thrombotic DisordersAnticoagulation Treatment+6 more
Xuanwu Hospital, Beijing 1,486
Not applicableWithdrawnNCT01869049
What this trial is testing

The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University
Not applicableNo Longer AvailableNCT03363334
What this trial is testing

Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Rigel Pharmaceuticals
Not applicableUnknownNCT05389007
What this trial is testing

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Johannes Gutenberg University Mainz 156
Large-scale testing (Phase 3)UnknownNCT02802605
What this trial is testing

Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients

Who this might be right for
Cirrhosis and Coagulation
Instituto de Investigación Marqués de Valdecilla 225
Not applicableStudy completedNCT03635177
What this trial is testing

Effect of Remote Ischemic Conditioning on Vascular Health in Stroke Patients

Who this might be right for
Stroke, Lacunar
University of Copenhagen 30
Large-scale testing (Phase 3)UnknownNCT01763658
What this trial is testing

Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Ain Shams University 100
Next Page